James Keck
7Patents
1h-index
8Co-inventors
44Inventor score
Filing activity: Aug 9, 2000 → Jun 28, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6803194B1 | Use of ribozymes for functionating genes | Chemistry; Metallurgy | 18 | Expired |
| US11959925B2 | Method of determining toxicity of an immunomodulatory drug for use in humans | Physics | 1 | Active |
| US11959926B2 | Method of determining toxicity of an immunomodulatory drug for use in humans preliminary class | Physics | 1 | Active |
| US11248236B2 | Non-HLA matched humanized NSG mouse model with patient-derived xenograft | Chemistry; Metallurgy | 0 | Active |
| US12196744B2 | Humanized mouse models for assessing immune cell therapy | Chemistry; Metallurgy | 0 | Active |
| US8207121B2 | Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound | Human Necessities | 0 | Active |
| US12409237B1 | Methods and models for assessing efficacy of immunotherapies | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.